| Elizabeth Leggiadro, PSYD | |
|
3500 John F Kennedy Pkwy Ste 200, Fort Collins, CO 80525-2635 | |
| (970) 889-8204 | |
| (888) 494-3756 |
| Full Name | Elizabeth Leggiadro |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 3500 John F Kennedy Pkwy Ste 200, Fort Collins, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043703655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Leggiadro, PSYD 508 Edwards St, Fort Collins, CO 80524-3812 Ph: (970) 214-1318 | Elizabeth Leggiadro, PSYD 3500 John F Kennedy Pkwy Ste 200, Fort Collins, CO 80525-2635 Ph: (970) 889-8204 |
News Archive
The results of an extensive new study funded by the National Institute for Health Research (NIHR), Ethnic-specific BMI cut-off points for obesity based on type 2 diabetes mellitus risk: a cohort study of 1.5 million people in England, presented at this year's European Congress on Obesity (ECO) and published simultaneously in the leading journal, The Lancet Diabetes & Endocrinology reveal that inaccurate and outdated interpretations of the standard Body Mass Index (BMI) values for patients from BAME backgrounds in England could potentially be putting their health at risk.
Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.
The ability to transfer a gene or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical research-including cancer, Alzheimer's disease, and diabetes.
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).
Those who had tumors removed from their livers with keyhole surgery had fewer complications, a better quality of life and similar long-term oncologic outcomes, a new PhD thesis shows.
› Verified 1 days ago
Molly Mclaren, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4216 Suncrest Ct, Fort Collins, CO 80525 Phone: 970-235-2072 | |
Keeley Hynes, PHD, NCSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 363 W Drake Rd, Fort Collins, CO 80526 Phone: 970-465-2977 | |
Dr. Saul Hopper, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 503 Remington St, Suite 102, Fort Collins, CO 80524 Phone: 970-221-0118 Fax: 970-221-0014 | |
Dr. Susan Kitchens, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 323 W Drake Rd, Suite 124, Fort Collins, CO 80526 Phone: 970-495-4686 Fax: 970-377-1230 | |
Dr. Sherry Elizabeth Gardner, PSY. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1217 Riverside Ave, Fort Collins, CO 80524 Phone: 970-494-4200 | |
Dr. Jeff Paulez, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 226 Remington St Ste 1, Fort Collins, CO 80524 Phone: 303-578-0708 | |
Aaron Emil Skalicky, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 608 E Harmony Rd, Suite 202, Fort Collins, CO 80525 Phone: 970-282-4428 Fax: 970-282-4393 |